Tuesday, March 25, 2014 9:24:33 AM
BioElectronics Device Alleviates Dental Surgical Trauma
Mar 25, 2014 08:30:00 (ET)
New study shows RecoveryRx(R) reduces pain and inflammation and accelerates healing
FREDERICK, Md., March 25, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at University of Genova, Valle Belbo Implant Center have completed a white paper detailing their results regarding the use of BioElectronics medical device, RecoveryRx(R) Therapy.
The white paper summarizes an observational study they conducted using RecoveryRx(R) Therapy in their post dental implant anesthesia and recovery protocol of patients at the Valle Belbo Implant Center. Dr. Operti noted, "The RecoveryRx device significantly impacts the quality of the post-operative experience by reducing edema, inflammation and pain."
The patients reported significant reductions in pain and facial swelling using standardized visual analog measurements. Follow-up interviews 24-48 hours following implant surgery reported return to normal chewing. Read complete results here. Dr. Operti had previously presented his results in September at the 16th International Implant Therapy Conference Verona, Italy.
Other Clinical Research
BioElectronics is conducting a series of clinical research studies using its medical devices for a variety of musculoskeletal pain conditions including, osteoarthritis of the knee, acute nonspecific lower back pain, 3(rd) molar extraction and hernia surgical recovery. A copy of this white paper can be found at http://www.bielcorp.com/clinical-evidence/ along with details of previously completed and published clinical trials.
MEDIA ALERT: BioElectronics Corporation CEO, Andrew Whelan will be interviewed by Michael Yorba live tomorrow on The Traders Network on Clear Channel Network. Interview details are as follows:
-- Date: Wednesday, March 26, 2014
-- Start Time: 11:30am PDT | 12:30pm MDT | 2:30pm EDT (U.S.)
-- Station: DFW 1190AM KFXR
-- Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch(R) Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx(R) Devices for chronic and post-operative wound care; Allay(R) Menstrual Pain Therapy; and HealFast(R) Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation
/Web site: http://www.bielcorp.com
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM